Cannabix Technologies Inc (BLOZF)

[euroconversions]

Dr. Bruce  Goldberger,  senior  advisor  to Cannabix, stated, “The Cannabix  Marijuana  Breathalyzer  utilizing FAIMS  will allow  the  Company  to zero in on impairment  with ‘recency  of  use’  like  no other  currently  known device  out  there.”  

Dr. Raj  Attariwala,  commented, “The  high resolving  power  of  the  FAIMS  device  with  its  capability  for  real time  detection of  THC  and its  metabolic  breakdown products  will aid  in  establishing  key  metrics  for  measuring in-vivo  THC  metabolism and  should  permit detection  capabilities  similar  to  that of  blood  tests.  The current human  testing  on of  the  FAIMS  based  Cannabix  Marijuana  Breathalyzer  has  shown impressive  results  thus  far.”

Rav  Mlait,  CEO  commented, “This testing  marks  a  major  milestone  for  the  Company's  research and development  of  the  FAIMS  technology  and  will  help guide  the  company  in  our  goal  in  developing  a device that can detect  levels  of  THC  in the  blood and correlate  this  with the  level  of  driver  impairment.”